Rand Paul's Biosimilar Drug Bill Could Cut Costs, Speed Patient Access
Reason · RC · trust 62/100
The Expedited Access to Biosimilars Act enables FDA approval of pharmaceutically equivalent biologic medications.
Read the original at Reason →
Open in TruthVane →